BONH
AMPH icon

Bank of New Hampshire’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bank of New Hampshire’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22K Sell
110
-96
-47% -$1.94K ﹤0.01% 517
2026
Q1 		$4.04K Buy
+206
New +$5.04K ﹤0.01% 499

Other funds holding AMPH

LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
LG
LAM Group Lake Oswego, Oregon $201M AUM 22.35% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Bank of New Hampshire's AMPH Position: Q2 2026 in Review

Bank of New Hampshire reduced its Amphastar Pharmaceuticals (AMPH) stake by 47% in Q2 2026, selling an estimated $1.94K and leaving 110 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

Bank of New Hampshire first reported a position in AMPH in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.04K in Q1 2026. 71 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Bank of New Hampshire held 110 shares of Amphastar Pharmaceuticals worth $2.22K as of Q2 2026.
  • Bank of New Hampshire sold 96 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $1.94K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Bank of New Hampshire's portfolio in Q2 2026, its #517 holding.
  • Bank of New Hampshire first reported a position in Amphastar Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Bank of New Hampshire's Amphastar Pharmaceuticals position peaked at $4.04K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.